Drug Approval | January 19, 2024
Zydus and Synthon inks licensing and supply agreement for Palbociclib Tablets for US market
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
The new ECO grade is made using renewable feedstock
Lack of technology transfer stands out as a formidable barrier
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
The product is expected to start contributing meaningfully to the revenue from FY25
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
Subscribe To Our Newsletter & Stay Updated
